Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone scan as a stratification variable in advanced prostate cancer.

G Knudson1, G Grinis, V Lopez-Majano

  • 1Division of Urology, University of Illinois Hospital, Chicago.

Cancer
|July 15, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

INVESTIGATING FACTORS INFLUENCING THE AMOUNT OF INJECTION PAIN IN THE ORAL CAVITY: A SYSTEMATIC REVIEW.

Georgian medical news·2025
Same author

Long non-coding RNAs TUG1 and MEG3 in patients with type 2 diabetes and their association with endoplasmic reticulum stress markers.

Journal of endocrinological investigation·2023
Same author

Circulating TRB3 and GRP78 levels in type 2 diabetes patients: crosstalk between glucose homeostasis and endoplasmic reticulum stress.

Journal of endocrinological investigation·2021
Same author

Effect of photobiomodulation on recovery from neurosensory disturbances after sagittal split ramus osteotomy: a triple-blind randomised controlled trial.

The British journal of oral & maxillofacial surgery·2020
Same author

Finding an Optimal Corneal Xenograft Using Comparative Analysis of Corneal Matrix Proteins Across Species.

Scientific reports·2019
Same author

Effect of temperature on the setting time of Mineral Trioxide Aggregate (MTA).

Journal of medicine and life·2017
Same journal

Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study.

Cancer·2026
Same journal

Bendamustine in indolent lymphoma: Letting the dust settle down.

Cancer·2026
Same journal

Top advances of the year: Bispecific antibodies in early lines of therapy in multiple myeloma.

Cancer·2026
Same journal

Direct oral anticoagulants and warfarin in atrial fibrillation patients with cancer by anticoagulation quality.

Cancer·2026
Same journal

Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

Cancer·2026
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
See all related articles

Serial bone scans reveal that advanced prostate cancer (Stage D-2) most commonly spreads to the vertebrae, ribs, and pelvis. Fewer affected bone areas correlate with longer survival, suggesting bone scan data

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiology

Background:

  • Prostate cancer, particularly Stage D-2, frequently metastasizes to bone.
  • Accurate staging and prognostication are crucial for effective treatment planning.

Purpose of the Study:

  • To analyze the patterns of bone metastases in Stage D-2 prostate cancer using technetium-99m bone scans.
  • To evaluate the prognostic significance of the extent of skeletal involvement.

Main Methods:

  • Retrospective review of serial technetium-99m bone scans in 76 patients with Stage D-2 prostate cancer.
  • Analysis of metastatic sites and correlation with progression-free interval and survival time.

Main Results:

  • The most common sites of skeletal metastases were vertebrae, ribs, and pelvis.

Related Experiment Videos

  • Patients with one or two involved skeletal areas demonstrated significantly longer progression-free intervals and survival times compared to those with three or more areas.
  • Increased number of metastatic bone sites correlated with poorer outcomes.
  • Conclusions:

    • The extent of skeletal involvement on bone scans is a significant prognostic factor in Stage D-2 prostate cancer.
    • Bone scan findings can potentially serve as a stratification variable in clinical trials for this patient population.